Herbicidal compounds
US-12479804-B2 · Nov 25, 2025 · US
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00)
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D498/00 |
| Official title | Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00) |
| Display label | Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00) |
| Total patents | 35 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Fused imide derivative
US-2025152719-A1 · May 15, 2025 · US
Compounds that inhibit MCL-1 protein
US-12024529-B2 · Jul 2, 2024 · US
Compounds that inhibit mcl-1 protein
US-2023271981-A1 · Aug 31, 2023 · US
Reagents for reversibly protecting biological molecules
US-11708375-B2 · Jul 25, 2023 · US
Compounds that inhibit MCL-1 protein
US-11685747-B2 · Jun 27, 2023 · US
Organic light emitting element
US-2023142329-A1 · May 11, 2023 · US
Herbicidal compounds
US-2022259153-A1 · Aug 18, 2022 · US
Cgrp antagonist compounds
US-2022251110-A1 · Aug 11, 2022 · US
Tricyclic compounds acting on crbn proteins
US-2022119376-A1 · Apr 21, 2022 · US
Organic light-emitting material and manufacturing method thereof, and organic light-emitting device
US-11254687-B2 · Feb 22, 2022 · US
Organic light-emitting material and manufacturing method thereof, and organic light-emitting device
US-2021403481-A1 · Dec 30, 2021 · US
Compounds that inhibit Mcl-1 protein
US-11001598-B2 · May 11, 2021 · US
Compounds that inhibit mcl-1 protein
US-2021040120-A1 · Feb 11, 2021 · US
Compounds that inhibit MCL-1 protein
US-10836779-B2 · Nov 17, 2020 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2020270303-A1 · Aug 27, 2020 · US
Compounds that inhibit mcl-1 protein
US-2020062780-A1 · Feb 27, 2020 · US
Reagents for reversibly protecting biological molecules
US-2019375763-A1 · Dec 12, 2019 · US
Compounds that inhibit Mcl-1 protein
US-10494381-B2 · Dec 3, 2019 · US
Macrocyclic proline derived hcv serine protease inhibitors
US-2019263860-A1 · Aug 29, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D498/00?
- CPC C07D498/00 is the Cooperative Patent Classification code for “Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00).”
- How many patents are filed under CPC C07D498/00 (Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00))?
- Our database includes 35 publications tagged with this CPC code.
- Is patent activity under CPC C07D498/00 growing?
- Publication counts under this code: 1 in 2024 vs 2 in 2025 (latest complete years).